Does SIMVASTATIN Cause Hyperbilirubinaemia? 55 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Hyperbilirubinaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.2% of all adverse event reports for SIMVASTATIN.
55
Reports of Hyperbilirubinaemia with SIMVASTATIN
0.2%
of all SIMVASTATIN reports
0
Deaths
51
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From SIMVASTATIN?
Of the 55 reports, 51 (92.7%) required hospitalization, and 19 (34.5%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which SIMVASTATIN Alternatives Have Lower Hyperbilirubinaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS